Daniela Urina Jassir, MD, FACC

Cardiologist • @MountSinaiMiami @Tulane • @uabmedicine • Colombiana 🇨🇴 ♥️• tweets my own • more CV prevention - less interventions

[Daniela Urina Jassir, MD, FACC @danielaurinaj]

@ACCinTouch Our stellar residents presenting at #ACC26. The future of cardiology 💜💛💚⚜️🌟 @SahilGhay @DrTcard @MountSinaiMiami

[Tarec K. Elajami, MD, FACC @DrTcard]

Honored to share our editorial in the European Heart Journal, written alongside @LaylaAbushamat & the incredible @CBallantyneMD, discussing pre-clinical work by Alcover et al. https://t.co/rSlefm800k https://t.co/BzmllNGznF
#REDUCEIT #EPA #Cvprev #Resolvins #CardioTwitter #EHJ

[American College of Cardiology @ACCinTouch]

🎙️ In a new episode of the #ACCEL Lite podcast, @cardio10s and @rblument1 discuss the top 🔟 things to know about the @ACCinTouch & @American_Heart 2026 Dyslipidemia Guideline.

🎧Tune in here: https://t.co/7PAYxLVpvu

#ClinicalGuidelines #Cholesterol #ASCVD #CardioX

[Tarec K. Elajami, MD, FACC @DrTcard]

@DrAlfaddagh @amrabbasmd @madonatelle

Our new paper on disparities in TAVR outcomes! Important gaps remain. We need to do better!

#Cardiotwitter #disparity #CVoutcomes

[Sahil Ghay @SahilGhay]

🚨 New paper out in Cardiovascular Revascularization Medicine 🚨

We analyzed 469,175 urban TAVR hospitalizations from 2016-2022.

The signal was clear:

🫀 Black and Hispanic patients had higher cardiometabolic burden
⚠️ Hispanic patients had higher mortality, MACE, AKI/dialysis, mechanical ventilation, transfusion, and cost
⚠️ Black patients had higher MACE, AKI, prolonged LOS, and CPR
✅ Stroke outcomes were similar across groups

The takeaway: TAVR has advanced dramatically, but equity in outcomes still needs to catch up.

Proud of our team and grateful to everyone involved.

https://t.co/1W52C1fLI3

#TAVR #Cardiology #HealthEquity #StructuralHeart #MedTwitter

[Daniela Urina Jassir, MD, FACC @danielaurinaj]

@CBallantyneMD @nationallipid @BCMHeart @vijay_nambi @LaylaAbushamat @virani_md Congratulations! 🫀@CBallantyneMD

[Christie Ballantyne @CBallantyneMD]

This is a tremendous honor. Virgil Brown has been an outstanding researcher, clinician, educator and leader @nationallipid This award is a tribute to my mentors, trainees, colleagues and collaborators @BCMHeart @vijay_nambi @LaylaAbushamat @virani_md

[Daniela Urina Jassir, MD, FACC @danielaurinaj]

Connecting with old and new friends at #ACC26. Loved to see my @TulaneCardio friends and attendings. @MountSinaiMiami also present at the Florida ACC reunion @SahilGhay @DrTcard @madonatelle 💜💛💚🎺🎷 @ACCinTouch @FloridaACC

[Daniela Urina Jassir, MD, FACC @danielaurinaj]

Our @MountSinaiMiami superb 🌟 residents @SahilGhay and Baneet presented our different projects on cardiovascular prevention at #ACC26 @ACCinTouch @DrTcard #metainflammation #CVprev #LipoproteinA

[Daniela Urina Jassir, MD, FACC @danielaurinaj]

@LaylaAbushamat @DrTcard @CBallantyneMD @ACCinTouch We miss you! You are the CV prevention star 🌟! We will be there in #ACC2027

[Daniela Urina Jassir, MD, FACC @danielaurinaj]

The best thing about ACC is not only connecting with friends but with family! 💚💜💛⚜️ 🎷 @CBallantyneMD @DrTcard @ACCinTouch #ACC2026 #cvprev #cardiovascularResearch

[NEJM @NEJM]

Presented at #ACC26:

Among patients with atherosclerotic cardiovascular disease, targeting an LDL cholesterol level below 55 mg per deciliter led to a lower 3-year risk of cardiovascular events than targeting a level below 70 mg per deciliter. Full Ez-PAVE trial results: https://t.co/q0vNdAoJJL

Editorial: Paving the Road toward Targeted Lipid Lowering https://t.co/zUwmo0r0n4

@ACCinTouch

[American College of Cardiology @ACCinTouch]

"I hope you take time to explore the city, eat some heart-healthy beignets (!), and enjoy all that the Big Easy has to offer – just don’t miss your presentation time!" - #ACCPresident @ChrisKramerMD

[Daniela Urina Jassir, MD, FACC @danielaurinaj]

Excellent conference in Miami by @BudoffMd highlighting the benefits and evolving role of CCTA in cardiology. This was a great start to the academic weekend @ACCinTouch 🎷 💜💛💚⚜️. @Heartflow #ACC26 #Cardiology #atherosclerosis

[Sahil Ghay @SahilGhay]

New data from 10,421 patients with metabolic syndrome: the C-reactive protein-triglyceride-glucose index (CTI) outperformed 23 cardiometabolic markers — including TyG, CRP, NLR, and non-HDL-C — as a predictor of CV mortality.

Patients in the highest CTI quartile had a 60% higher risk of CV death.

Integrating inflammation + metabolic stress into a single index may be the key to better risk stratification in MetS.
📄 Journal of Clinical Lipidology (2026)
#Cardiology #MetabolicSyndrome #CVDRisk #Inflammation #PreventiveCardiology

https://t.co/CAWw1R35q7

[Keith C. Ferdinand, MD, FACC, FAHA, FNLA @kcferdmd]

Here, I discuss why low blood pressure (BP) should not delay heart failure (HF) treatment.

This podcast is part of the Managing HF Across the Spectrum: From Recognizing Symptoms to Implementing Appropriate Treatment initiative, supported by Bayer AG.

https://t.co/1bpOrmoUT7

[American College of Cardiology @ACCinTouch]

Don’t forget to check out the poster presentations at #ACCMidEast!

#ACCIntl

[Bashaer Gheyath MD FACC 🫀👩🏻‍⚕️ @Bgheyath]

Can’t believe it’s been since ACC23 ! Loved connecting with some of my US ACC peeps! Can’t wait for the next one ✨💕#ACCMidEast

[Daniela Urina Jassir, MD, FACC @danielaurinaj]

@MountSinaiMiami

#cardiometabolichealth #prevention
#inflammation #metabolicsyndrome

[American College of Cardiology @ACCinTouch]

Don’t forget to check out the poster presentations at #ACCMidEast!

#ACCIntl

[Daniela Urina Jassir, MD, FACC @danielaurinaj]

MetS and CV mortality 🌟🫀

#cardiometabolichealth #prevention

[Bashaer Gheyath MD FACC 🫀👩🏻‍⚕️ @Bgheyath]

Don’t miss out! 🔬🫀CardioTwitter! “At #ACCMidEast presented how the Triglyceride-Glucose Index predicts CV mortality in metabolic syndrome. Important insights into precision risk stratification in diverse populations. 🔬❤️ the team is here from Miami ! 🌴@ElajamiMohamad